Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc. (SUPN)
Filing Type: Form 8-K (Current Report)
Date of Report: April 22, 2026
Subject: Announcement of the upcoming release of financial results for the first quarter of 2026.
Key Financial Metrics
This filing is a procedural announcement and does not contain specific financial data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity for the first quarter of 2026 or any prior period.
Material Changes
No material changes to financial condition or operations are reported in this document. The filing solely notifies investors of the scheduled date for the release of Q1 2026 results.
Guidance, Outlook, and Management Commentary
- Results Release Date: After market close on Tuesday, May 5, 2026.
- Conference Call: Scheduled for Tuesday, May 5, 2026, at 4:30 p.m. E.T.
- Content: The call will discuss first quarter 2026 financial and business results.
- Exhibits: A press release dated April 22, 2026, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the actual financial results when released on May 5, 2026.
- Review the press release (Exhibit 99.1) for any preliminary highlights not included in this 8-K summary.
- Listen to the conference call on May 5, 2026, for management commentary on Q1 performance and future outlook.
- Check for any subsequent filings that may update the guidance or address risks mentioned in the upcoming earnings release.